Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,514 | 1 | 48.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,698 | 6 | 32.2% |
| Food and Beverage | $3,029 | 151 | 17.1% |
| Travel and Lodging | $476.69 | 3 | 2.7% |
| Education | $1.79 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $8,915 | 8 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $6,314 | 38 | $0 (2020) |
| Stryker Corporation | $553.02 | 8 | $0 (2024) |
| Lundbeck LLC | $358.79 | 26 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $351.61 | 14 | $0 (2020) |
| Alkermes, Inc. | $329.48 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $284.99 | 18 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $243.70 | 11 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $185.98 | 10 | $0 (2020) |
| Allergan, Inc. | $104.79 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.02 | 8 | Stryker Corporation ($553.02) |
| 2023 | $8,928 | 9 | EMD Serono, Inc. ($8,915) |
| 2020 | $1,278 | 16 | Otsuka America Pharmaceutical, Inc. ($1,121) |
| 2019 | $6,114 | 82 | Otsuka America Pharmaceutical, Inc. ($5,139) |
| 2018 | $672.99 | 36 | Teva Pharmaceuticals USA, Inc. ($158.38) |
| 2017 | $174.02 | 11 | Sunovion Pharmaceuticals Inc. ($65.66) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Stryker Corporation | ANCHORAGE (Device) | Food and Beverage | In-kind items and services | $155.34 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 04/20/2024 | Stryker Corporation | ACTISHIELD (Device) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 04/19/2024 | Stryker Corporation | INFINITY ADAPTIS (Device) | Food and Beverage | In-kind items and services | $83.05 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 04/19/2024 | Stryker Corporation | INFINITY ADAPTIS (Device) | Food and Beverage | In-kind items and services | $83.05 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 04/18/2024 | Stryker Corporation | INFINITY ADAPTIS (Device) | Food and Beverage | In-kind items and services | $129.34 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 04/18/2024 | Stryker Corporation | ALLOMATRIX (Device) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: BONE SUBSTITUTES | ||||||
| 04/18/2024 | Stryker Corporation | INFINITY ADAPTIS (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 01/08/2024 | Stryker Corporation | ACTISHIELD (Device) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 08/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | EMD Serono, Inc. | Evobrutinib | Consulting Fee | Cash or cash equivalent | $8,513.75 | General |
| 06/26/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $54.00 | General |
| 06/24/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $61.20 | General |
| 06/24/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| 06/24/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| 06/23/2023 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $211.05 | General |
| 06/23/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.65 | General |
| 06/23/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| 04/22/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $702.00 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $351.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/25/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: PSYCHIATRY | ||||||
| 02/25/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: PSYCHIATRY | ||||||
| 02/17/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: NEUROLOGY | ||||||
| 02/13/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 139 | 324 | $82,000 | $16,978 |
| 2022 | 2 | 166 | 382 | $98,000 | $19,637 |
| 2021 | 1 | 170 | 518 | $130,145 | $28,379 |
| 2020 | 2 | 364 | 589 | $117,245 | $22,966 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 221 | $55,250 | $11,535 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 90 | $22,500 | $4,259 | 18.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 13 | $4,250 | $1,184 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 282 | $70,500 | $12,874 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 74 | $18,500 | $4,311 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $4,875 | $1,264 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 12 | $4,125 | $1,189 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 501 | $125,895 | $27,084 | 21.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 17 | $4,250 | $1,295 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 169 | 382 | $89,320 | $19,992 | 22.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 111 | 120 | $26,620 | $2,203 | 8.3% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 84 | 87 | $1,305 | $771.12 | 59.1% |
About Dr. Syed Rizvi, M.D
Dr. Syed Rizvi, M.D is a Psychiatry healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801089289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Rizvi, M.D has received a total of $17,719 in payments from pharmaceutical and medical device companies, with $553.02 received in 2024. These payments were reported across 162 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($8,514).
As a Medicare-enrolled provider, Rizvi has provided services to 839 Medicare beneficiaries, totaling 1,813 services with total Medicare billing of $87,961. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lexington, KY
- Active Since 08/20/2007
- Last Updated 05/26/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1801089289
Products in Payments
- Evobrutinib $8,514
- ABILIFY MAINTENA (Drug) $6,439
- INGREZZA (Drug) $351.61
- INFINITY ADAPTIS (Device) $308.63
- INVEGA SUSTENNA (Drug) $268.43
- AUSTEDO (Drug) $243.70
- ARISTADA (Drug) $242.78
- REXULTI (Drug) $233.04
- LATUDA (Drug) $185.98
- ANCHORAGE (Device) $155.34
- VRAYLAR (Drug) $117.91
- Aristada 441 mg (Drug) $86.70
- ALLOMATRIX (Device) $44.64
- ACTISHIELD (Device) $44.41
- PERSERIS (Drug) $25.02
- SPRAVATO (Drug) $16.56
- HETLIOZ (Drug) $15.00
- NUPLAZID (Drug) $14.19
- VYVANSE (Drug) $11.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lexington
Mark Wright, M.d, M.D
Psychiatry — Payments: $619,046
Dr. Steven Croley, Md, MD
Psychiatry — Payments: $111,876
Dr. Paolo Cassano, Md, Phd, MD, PHD
Psychiatry — Payments: $12,649
Kathleen Lundvall, Md, MD
Psychiatry — Payments: $9,100
Dr. Getulio Tovar, M.d, M.D
Psychiatry — Payments: $9,055
Mr. Saeed Hamid, M.d, M.D
Psychiatry — Payments: $8,148